Genpact CEO Suggests AI Could Reduce IT Workload Potentially Slow Employment Growth Alphabet Inc Expands Gemini Enterprise Agent Marketplace Through Amdocs Partnership Home Depot Comparable Sales Narrow Gap with Lowes Potentially Signaling Stock Performance Alignment Ferrari Shares Decline After Unveiling First Electric Vehicle Amid Market Skepticism Turkish Tourists Flock to Greece as Rising Costs Deter Greek Visitors Genpact CEO Suggests AI Could Reduce IT Workload Potentially Slow Employment Growth Avalon Holdings Q4 2025 Earnings Loss Reported as Stock Rises in Absence of Analyst Estimates StoneX Group Inc SNEX Q1 2026 Earnings EPS Surges Past Estimates with 365 Beat MP Materials Q1 2026 Earnings Strong Profitability Beat Drives Share Rally Grove Collaborative Holdings GROV Q1 2026 Earnings Narrowerthanexpected loss signals improved cost discipline MOS Q1 2026 Earnings EPS Falls Sharply Short of Estimates Stock Rises on Other Factors AVGO Q1 2026 Earnings Slight EPS Miss Amid Mixed Signals Kestrel Group Ltd KG Faces Selling Pressure Testing Key Support Levels Olaplex Holdings OLPX Holds Steady at 205 as Key Support and Resistance Define Trading Range Gran Tierra Energy GTE Holds Steady Near Support A Day of Marginal Gains Jackson Financial JXN Edges Lower as Support Levels Face Test PJT Partners Inc PJT Edges Higher by 115 as Stock Tests Key Resistance Levels China Urges APEC Cooperation Amid Commerce Ministers Absence Due to Urgent Official Business OLOX Q3 2023 Earnings SmallerThanExpected Loss Surprises Analysts GSK GSK Holds Steady With Modest Gains as Pharma Sector Navigates Uncertainty Profusa Inc PFSA Facing Resistance at 038 as Shares Dip 321 BRC Inc BRCC Edges Higher as Investors Eye Key Resistance Levels Crane Harbor Acquisition Corp II CRAN Holds Steady Near Support as Trading Volume Remains Light Ivanhoe Electric IE Slips 294 as Key Support Levels Come into Focus Tamboran Resources TBN Gains Ground Testing Key Resistance Levels Amid Sector Optimism Andretti Acquisition Corp II Warrant POLEW Holds Steady Near Support at 025 Akebia Therapeutics AKBA Holds Steady at 102 as Support and Resistance Levels Tighten